Global Automatic Data Capture (ADC) Market To Grow At A CAGR Of 7.01% During The Period 2017-2021 Key Vendors – Datalogic, Honeywell International, Zebra Technologies, Generalscan, Shenzhen Unique Electronic International, RIOTEC, Eurotech

Researchmoz added Most up-to-date research on "Global Automatic Data Capture (ADC) Market 2017-2021" to its huge collection of research reports.

Automatic data capture (ADC) involves capturing data automatically using equipment, such as barcode readers, or technologies, including RFID and speech recognition. Automatic data capture (ADC) involves the use of magnetic stripe readers, optical character recognition, barcode scanners, RFID, and speech recognition to capture data automatically. It is a method used for recognizing objects, gathering information about them, and feeding it to computer systems without any human involvement. ADC has several advantages, including inventory management, reduction in data entry errors, and consumption of less time.

Technavios analysts forecast the global automatic data capture (ADC) market to grow at a CAGR of 7.01% during the period 2017-2021.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1293317

Covered in this report
The report covers the present scenario and the growth prospects of the global automatic data capture (ADC) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the shipment of RFID, barcode scanners, barcode printers, and wearable scanners for various applications.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Global Automatic Data Capture (ADC) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Datalogic
Honeywell International
Zebra Technologies
Generalscan
Shenzhen Unique Electronic International
RIOTEC
Eurotech

Browse Detail Report With Full TOC @ http://www.researchmoz.us/global-automatic-data-capture-adc-market-2017-2021-report.html

Other prominent vendors
Acreo Swedish ICT
Alien Technology
Avery Dennison
Checkpoint Systems
CipherLab
CoreRFID
FEIG ELECTRONIC
Fujitsu
GAO RFID
Impinj
ORBCOMM
Quantum Resources Management
Mojix
Mobile Aspects
Nedap
RFID4U
RF IDeas
Skytron
JADAK
Solstice Medical
SMARTRAC
InnerSpace
SATO VICINITY
TAGSYS RFID
Terso Solutions
Tellago
TIBCO Software
Tyco Retail Solutions
Thinfilm
ThingMagic
Unitech Electronics
WaveMark
SML Group
Aceeca
Advantech
Bluebird
CipherLab
DENSO
Handheld Group
Juniper Systems
NCR
Opticon Sensors Europe
TouchStar Technologies
ZEBEX Industries

Market driver
Increasing number of RFID applications
For a full, detailed list, view our report

Market challenge
Security concerns
For a full, detailed list, view our report

Market trend
Growing popularity of smart factories
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1293317

Global Antibody Drug Conjugates (ADC) Market Analysis, Pipeline Drugs, Regulations Opportunities and Forecasts (2017-2022)

Researchmoz added Most up-to-date research on "Global Antibody Drug Conjugates (ADC) Market - Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022) - By Region (N. America, Europe, APAC, RoW); By Country (US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa)" to its huge collection of research reports.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antibody Drug Conjugates Market on the basis of Analysis By Drug (Adcetris, Kadcyla), Pipeline Analysis (Developer, Phase, Indication, Status, Cytotoxic Payload, Linker, Target), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Singapore, Brazil and South Africa).

Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1048255

According to Azoth Analytics research report, “Global Antibody Drug Conjugates  (ADC) Market – Analysis By Drugs  (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, global market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 – 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.

Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years

The report titled, “Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, has covered and analysed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Antibody Drug Conjugates Market (ADC) Market
- Adcetris Market
- Kadcyla Market
- ADC Pipeline - By Developer, Phase, Indication and Status
- ADC Pipeline - By Cytotoxic Payload, Linker and Target

Regional Markets – N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022)

- Antibody Drug Conjugates Market (ADC) Market
- Adcetris Market
- Kadcyla Market
- ADC Pipeline - By Developer, Phase, Indication and Status
- ADC Pipeline - By Cytotoxic Payload, Linker and Target

Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Antibody Drug Conjugates Market (ADC) Market

Other Report Highlights:

- Market Dynamics – Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- SWOT Analysis
- Policy and Regulation
- Company Analysis - Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi,  AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation3.1 Focus on marketing ADCs at lower cost in Asia Pacific region
3.2 Multiple Licensing and Collaboration
3.3 Outsourcing of ADC manufacturing to CMOs

4. Antibody Drug Conjugates Product Overview

5. Global Antibody Drug Conjugates Market: Growth and Forecast
5.1 By Value (2012-2016)
5.2 By Value (2017-2022)

6. Global Antibody Drug Conjugates Market: By Drug (Adcetris, Kadcyla)
6.1 Global Antibody Drug Conjugates Market-By Drug: Breakdown (%)
6.1.1 Global Antibody Drug Conjugates Market Size and Share, By Drug, 2016
6.1.2 Global Antibody Drug Conjugates Market Size and Share, By Drug, 2022
6.2 Global Adcetris Market Overview
6.2.1 By Value (2012-2016)
6.2.2 By Value (2017-2022)
6.3 Global Kadcyla Market Overview
6.3.1 By Value (2013-2016)
6.3.2 By Value (2017-2022)

7. Global Antibody Drug Conjugates Market: Pipeline Analysis
7.1 By Developer, Phase, Indication and Status
7.2 By Cytotoxic Payload, Linker and Target

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1048255

Global Antibody Drug Conjugates (ADC) Market Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)

Researchmoz added Most up-to-date research on "Global Antibody Drug Conjugates (ADC) Market - Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022) - By Region (N. America, Europe, APAC, RoW); By Country (US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa)" to its huge collection of research reports.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antibody Drug Conjugates Market on the basis of Analysis By Drug (Adcetris, Kadcyla), Pipeline Analysis (Developer, Phase, Indication, Status, Cytotoxic Payload, Linker, Target), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Singapore, Brazil and South Africa).

Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1048255

According to Azoth Analytics research report, “Global Antibody Drug Conjugates  (ADC) Market – Analysis By Drugs  (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, global market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 – 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.

Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years

The report titled, “Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, has covered and analysed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Antibody Drug Conjugates Market (ADC) Market
- Adcetris Market
- Kadcyla Market
- ADC Pipeline - By Developer, Phase, Indication and Status
- ADC Pipeline - By Cytotoxic Payload, Linker and Target

Regional Markets – N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Antibody Drug Conjugates Market (ADC) Market
- Adcetris Market
- Kadcyla Market
- ADC Pipeline - By Developer, Phase, Indication and Status
- ADC Pipeline - By Cytotoxic Payload, Linker and Target

Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)

- Antibody Drug Conjugates Market (ADC) Market

Other Report Highlights:

- Market Dynamics – Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- SWOT Analysis
- Policy and Regulation
- Company Analysis - Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi,  AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1048255

Global Antibody Drug Conjugates (ADC) Market Opportunities and Forecasts (2017-2022)

Researchmoz added Most up-to-date research on "Global Antibody Drug Conjugates (ADC) Market - Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022) - By Region (N. America, Europe, APAC, RoW); By Country (US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa)" to its huge collection of research reports.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antibody Drug Conjugates Market on the basis of Analysis By Drug (Adcetris, Kadcyla), Pipeline Analysis (Developer, Phase, Indication, Status, Cytotoxic Payload, Linker, Target), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Singapore, Brazil and South Africa).

Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1048255

According to Azoth Analytics research report, “Global Antibody Drug Conjugates  (ADC) Market – Analysis By Drugs  (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, global market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 – 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.

Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years

The report titled, “Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, has covered and analysed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Antibody Drug Conjugates Market (ADC) Market
- Adcetris Market
- Kadcyla Market
- ADC Pipeline - By Developer, Phase, Indication and Status
- ADC Pipeline - By Cytotoxic Payload, Linker and Target

Regional Markets – N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Antibody Drug Conjugates Market (ADC) Market
- Adcetris Market
- Kadcyla Market
- ADC Pipeline - By Developer, Phase, Indication and Status
- ADC Pipeline - By Cytotoxic Payload, Linker and Target

Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)

- Antibody Drug Conjugates Market (ADC) Market

Other Report Highlights:

- Market Dynamics – Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- SWOT Analysis
- Policy and Regulation
- Company Analysis - Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi,  AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1048255